Adenylate kinase activity in the cerebrospinal fluid of children with tuberculous meningitis and its relationship to neurological outcome

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 3, 1997, Pages 275-280

  Carlini, Sophia M ^a   Beyers, Nulda ^a   Schoeman, Johan F ^a   Nel, Etienne D ^a   Truter, Ernest J ^b   Donald, Peter R ^a,c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b Cape Technicon   (South Africa)

^c NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ETHIONAMIDE; ISONIAZID; LACTIC ACID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; ENZYME ACTIVITY; HEARING; HUMAN; INFANT; INTELLIGENCE; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; VISION;

EID: 0030792149     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709019042     Document Type: Article

References (17)

1. Berman S, Kibel MA, Fourie PB, Strebel PM. Childhood tuberculosis and tuberculous meningitis: High incidence rates in the Western Cape of South Africa. Tubercle Lung Dis 73: 38-44, 1992.
2. Swart S, Briggs RS, Millac PA. Tuberculous meningitis in Asian patients. Lancet 2: 15-16, 1981.
3. Naughten E, Eindling AM, Newton R, Bower BD. Tuberculous meningitis in children - recent experience in two English centres. Lancet 2: 973-975, 1981.
4. Dastur D, Lalitha VS, Udani PM, Parekh U. The brain and meninges in tuberculous meningitis gross pathology in 100 cases and pathogenesis. Neurol India 18: 86-100, 1970.
5. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Serial scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol 10: 320-329, 1995.
6. Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet 1: 582-596, 1948.
7. Bollensen E, Grange HW. Adenylate kinase enzyme activity in cases of brain infarction. Acta Neurol Scand 79: 53-58, 1989.
8. Ronquist G, Terent A. Cerebrospinal fluid markers of disturbed brain cell metabolism. Progr Neurobiol 18: 167-180, 1982.
9. Edgren E, Hedstrand U, Nordin M, Tydin E, Ronquist G. Prediction of outcome after cardiac arrest. Crit Care Med 15: 820-825, 1987.
10. Jonsson I, Briem H, Ronquist G. Cerebrospinal fluid content of adenylate kinase, lactate and glutathione in patients with meningitis. Scand J Infect Dis 11: 11-15, 1979.
11. Schoeman J, Donald PR, van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: Comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol 33: 396-405, 1991.
12. Fourie PB. Patterns of tuberculin hypersensitivity in South Africa. Tubercle 64: 167-179, 1983.
13. Hische EA, van der Helm HJ, Blanken HI. Determination of adenylate kinase activity in cerebrospinal fluid. Clin Chem 30: 333-334, 1984.
14. Ronquist G, Callerud J, Niklasson F, Friman G. Studies of ochemical markers in cerebrospinal fluid in patients with meningoencephalitis. Infect Immun 48: 729-734, 1985.
15. Åberg T, Ronquist G, Tydén H, Brunnkvist S, Hultman J, Bergström K, Lilja A. Adverse effects on the brain in cardiac operations as assessed by biochemical, psychometric, and radiologic methods. J Thorac Cardiovasc Surg 87: 99-105, 1984.
16. . Frithz G, Ericsson P, Ronquist G. Adenylate kinase activity in cerebrospinal fluid in connection with transitory ischaemic attacks. Upsala J Med Sci 82: 11-14, 1977.
17. Udani PM, Parekh UC, Dastur DK. Neurological and related syndromes in CNS tuberculosis. Clinical features and pathogenesis. J Neurol Sci 14: 341-357, 1971.